TFRC and neoplasm: Here, we showed that the TFRC expression level is a candidate tumor marker for OSCC development from dysplasia and that TFRC itself could possibly be a therapeutic target for OSCC with the development of the anti-human TFRC-specific antibody described in this manuscript.